terfenadine (Seldane)
Jump to navigation
Jump to search
Introduction
Tradename: Seldane. FDA approved in 1985. Withdrawn from US market in 1998[3].
Contraindications
Caution: do not use with liver failure
Dosage
Pharmacokinetics
- Fexofenadine is active metabolite
elimination via liver
elimination via kidney
Adverse effects
Drug interactions
More general terms
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 34
- ↑ Jump up to: 3.0 3.1 Fresno Bee, Dec. 2000